{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:23:54Z","timestamp":1787772234624,"version":"build-2784847793"},"posted":{"date-parts":[[2026,8,26]]},"group-title":"In Review","reference-count":62,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,8,25]]},"abstract":"<title>Abstract<\/title>\n                <p>Although histone deacetylase (HDAC) inhibitors have shown therapeutic potential in aging and Alzheimer's disease (AD), direct comparisons of nonselective and selective HDAC inhibitors across aging and AD models are lacking. We compared the effects of the broad-spectrum HDAC inhibitor valproic acid (VPA) and the selective class I HDAC inhibitors entinostat (MS-275) and tacedinaline (CI-994) in 3-, 12-, and 18-month-old wild-type and APP\/PS1 mice. Mice received 30 days of treatment, followed by a series of behavioral tests assessing different memory domains. Brain tissue was then analyzed for molecular and pathological changes. Both MS-275 and CI-994 improved recognition memory and short-term working memory in 12- and 18-month-old APP\/PS1 mice, whereas only CI-994 restored long-term spatial reference memory. CI-994 increased hippocampal synapse-related gene expression and H3K9 acetylation at their promoters, consistent with improved hippocampus-dependent memory. In contrast, MS-275 enhanced synapse-related gene expression and H3K9 acetylation, in the prefrontal cortex (PFC), corresponding to improvements in recognition and working memory. MS-275 also significantly reduced amyloid plaque burden in the hippocampus and PFC, whereas both MS-275 and CI-994 decreased microglial density in APP\/PS1 mice. These findings demonstrate distinct spatial and functional effects of selective HDAC inhibition in AD. CI-994 primarily targets hippocampal synaptic plasticity to improve long-term spatial memory, whereas MS-275 preferentially modulates PFC synaptic function and reduces amyloid pathology, leading to improved recognition and working memory. Together, these results identify region-specific HDAC mechanisms that differentially regulate cognitive function and AD pathology, supporting selective HDAC inhibition as a promising therapeutic strategy for AD.<\/p>","DOI":"10.21203\/rs.3.rs-10816126\/v1","type":"posted-content","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:16:13Z","timestamp":1787732173000},"source":"Crossref","is-referenced-by-count":0,"title":["Histone Deacetylase Inhibitors Improve Memory Function and Decrease Neuropathology in APP\/PS1 Mice"],"prefix":"10.21203","author":[{"given":"Bryan","family":"McClarty","sequence":"first","affiliation":[{"name":"Northwestern University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisa","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Northwestern University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Dong","sequence":"additional","affiliation":[{"name":"Northwestern University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland M","year":"2009","unstructured":"Haberland M, Montgomery RL, Olson EN (2009) The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet 10(1):32\u201342","journal-title":"Nat Rev Genet"},{"issue":"1\u20132","key":"ref2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1615\/CritRevOncog.2015012997","article-title":"Histone deacetylases and mechanisms of regulation of gene expression","volume":"20","author":"Chen HP","year":"2015","unstructured":"Chen HP, Zhao YT, Zhao TC (2015) Histone deacetylases and mechanisms of regulation of gene expression. Crit Rev Oncog 20(1\u20132):35\u201347","journal-title":"Crit Rev Oncog"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hipo.22116","article-title":"Region- and age-specific patterns of histone acetylation related to spatial and cued learning in the water maze","volume":"23","author":"Dagnas M","year":"2013","unstructured":"Dagnas M, Mons N (2013) Region- and age-specific patterns of histone acetylation related to spatial and cued learning in the water maze. Hippocampus 23(7):581\u2013591","journal-title":"Hippocampus"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hipo.22406","article-title":"Post-training, intrahippocampal HDAC inhibition differentially impacts neural circuits underlying spatial memory in adult and aged mice","volume":"25","author":"Dagnas M","year":"2015","unstructured":"Dagnas M, Micheau J, Decorte L, Beracochea D, Mons N (2015) Post-training, intrahippocampal HDAC inhibition differentially impacts neural circuits underlying spatial memory in adult and aged mice. Hippocampus 25(7):827\u2013837","journal-title":"Hippocampus"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroscience.2019.08.020","article-title":"Histone Deacetylase Inhibitor MS-275 Alleviates Postoperative Cognitive Dysfunction in Rats by Inhibiting Hippocampal Neuroinflammation","volume":"417","author":"Wu Y","year":"2019","unstructured":"Wu Y, Dou J, Wan X, Leng Y, Liu X, Chen L et al (2019) Histone Deacetylase Inhibitor MS-275 Alleviates Postoperative Cognitive Dysfunction in Rats by Inhibiting Hippocampal Neuroinflammation. Neuroscience 417:70\u201380","journal-title":"Neuroscience"},{"issue":"19","key":"ref6","first-page":"10194","article-title":"The inhibitory effects of class I histone deacetylases on hippocampal neuroinflammatory regulation in aging mice with postoperative cognitive dysfunction","volume":"24","author":"Yang CX","year":"2020","unstructured":"Yang CX, Bao F, Zhong J, Zhang L, Deng LB, Sha Q et al (2020) The inhibitory effects of class I histone deacetylases on hippocampal neuroinflammatory regulation in aging mice with postoperative cognitive dysfunction. Eur Rev Med Pharmacol Sci 24(19):10194\u201310202","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"674745","DOI":"10.3389\/fnins.2021.674745","article-title":"Dose Effects of Histone Deacetylase Inhibitor Tacedinaline (CI-994) on Antipsychotic Haloperidol-Induced Motor and Memory Side Effects in Aged Mice","volume":"15","author":"McClarty B","year":"2021","unstructured":"McClarty B, Rodriguez G, Dong H (2021) Dose Effects of Histone Deacetylase Inhibitor Tacedinaline (CI-994) on Antipsychotic Haloperidol-Induced Motor and Memory Side Effects in Aged Mice. Front Neurosci 15:674745","journal-title":"Front Neurosci"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/npp.2008.229","article-title":"Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model","volume":"34","author":"Ricobaraza A","year":"2009","unstructured":"Ricobaraza A, Cuadrado-Tejedor M, P\u00e9rez-Mediavilla A, Frechilla D, Del R\u00edo J, Garc\u00eda-Osta A (2009) Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 34(7):1721\u20131732","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease","volume":"35","author":"Kilgore M","year":"2010","unstructured":"Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, Sweatt JD et al (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35(4):870\u2013880","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2011-110080","article-title":"Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression","volume":"26","author":"Govindarajan N","year":"2011","unstructured":"Govindarajan N, Agis-Balboa RC, Walter J, Sananbenesi F, Fischer A (2011) Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression. J Alzheimers Dis 26(1):187\u2013197","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/hipo.20883","article-title":"Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease","volume":"22","author":"Ricobaraza A","year":"2012","unstructured":"Ricobaraza A, Cuadrado-Tejedor M, Marco S, P\u00e9rez-Ota\u00f1o I, Garc\u00eda-Osta A (2012) Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus 22(5):1040\u20131050","journal-title":"Hippocampus"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.expneurol.2012.10.005","article-title":"Mercaptoacetamide-based class II HDAC inhibitor lowers A\u03b2 levels and improves learning and memory in a mouse model of Alzheimer's disease","volume":"239","author":"Sung YM","year":"2013","unstructured":"Sung YM, Lee T, Yoon H, DiBattista AM, Song JM, Sohn Y et al (2013) Mercaptoacetamide-based class II HDAC inhibitor lowers A\u03b2 levels and improves learning and memory in a mouse model of Alzheimer's disease. Exp Neurol 239:192\u2013201","journal-title":"Exp Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brainresbull.2021.12.004","article-title":"Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats","volume":"179","author":"Badrikoohi M","year":"2022","unstructured":"Badrikoohi M, Esmaeili-Bandboni A, Babaei P (2022) Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats. Brain Res Bull 179:49\u201356","journal-title":"Brain Res Bull"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models","volume":"205","author":"Qing H","year":"2008","unstructured":"Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, Cai F et al (2008) Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. J Exp Med 205(12):2781\u20132789","journal-title":"J Exp Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuroscience.2014.02.012","article-title":"Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation","volume":"266","author":"Noh H","year":"2014","unstructured":"Noh H, Seo H (2014) Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation. Neuroscience 266:255\u2013265","journal-title":"Neuroscience"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/cns.12186","article-title":"Valproic acid reduces neuritic plaque formation and improves learning deficits in APP(Swe) \/PS1(A246E) transgenic mice via preventing the prenatal hypoxia-induced down-regulation of neprilysin","volume":"20","author":"Wang Z","year":"2014","unstructured":"Wang Z, Zhang XJ, Li T, Li J, Tang Y, Le W (2014) Valproic acid reduces neuritic plaque formation and improves learning deficits in APP(Swe) \/PS1(A246E) transgenic mice via preventing the prenatal hypoxia-induced down-regulation of neprilysin. CNS Neurosci Ther 20(3):209\u2013217","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12035-014-8751-4","article-title":"Valproic acid alleviates memory deficits and attenuates amyloid-\u03b2 deposition in transgenic mouse model of Alzheimer's disease","volume":"51","author":"Xuan AG","year":"2015","unstructured":"Xuan AG, Pan XB, Wei P, Ji WD, Zhang WJ, Liu JH et al (2015) Valproic acid alleviates memory deficits and attenuates amyloid-\u03b2 deposition in transgenic mouse model of Alzheimer's disease. Mol Neurobiol 51(1):300\u2013312","journal-title":"Mol Neurobiol"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/abbs\/gmw085","article-title":"Gender difference in valproic acid-induced neuroprotective effects on APP\/PS1 double transgenic mice modeling Alzheimer's disease","volume":"48","author":"Long Z","year":"2016","unstructured":"Long Z, Zeng Q, Wang K, Sharma A, He G (2016) Gender difference in valproic acid-induced neuroprotective effects on APP\/PS1 double transgenic mice modeling Alzheimer's disease. Acta Biochim Biophys Sin (Shanghai) 48(10):930\u2013938","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fnagi.2019.00062","article-title":"Valproic Acid Stimulates Hippocampal Neurogenesis via Activating the Wnt\/\u03b2-Catenin Signaling Pathway in the APP\/PS1\/Nestin-GFP Triple Transgenic Mouse Model of Alzheimer's Disease","volume":"11","author":"Zeng Q","year":"2019","unstructured":"Zeng Q, Long Z, Feng M, Zhao Y, Luo S, Wang K et al (2019) Valproic Acid Stimulates Hippocampal Neurogenesis via Activating the Wnt\/\u03b2-Catenin Signaling Pathway in the APP\/PS1\/Nestin-GFP Triple Transgenic Mouse Model of Alzheimer's Disease. Front Aging Neurosci 11:62","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/NEN.0b013e318283114a","article-title":"Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model","volume":"72","author":"Zhang ZY","year":"2013","unstructured":"Zhang ZY, Schluesener HJ (2013) Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model. J Neuropathol Exp Neurol 72(3):178\u2013185","journal-title":"J Neuropathol Exp Neurol"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/s41386-018-0073-1","article-title":"Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism","volume":"43","author":"Ma K","year":"2018","unstructured":"Ma K, Qin L, Matas E, Duffney LJ, Liu A, Yan Z (2018) Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism. Neuropsychopharmacology 43(8):1779\u20131788","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"e0213095","DOI":"10.1371\/journal.pone.0213095","article-title":"Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model","volume":"14","author":"Kalin JH","year":"2019","unstructured":"Kalin JH, Eroglu A, Liu H, Holtzclaw WD, Leigh I, Proby CM et al (2019) Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model. PLoS ONE 14(3):e0213095","journal-title":"PLoS ONE"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12876-022-02101-7","article-title":"MS275 as Class I HDAC inhibitor displayed therapeutic potential on malignant ascites by iTRAQ-based quantitative proteomic analysis","volume":"22","author":"Du L","year":"2022","unstructured":"Du L, Wang D, Wei X, Liu C, Xiao Z, Qian W et al (2022) MS275 as Class I HDAC inhibitor displayed therapeutic potential on malignant ascites by iTRAQ-based quantitative proteomic analysis. BMC Gastroenterol 22(1):29","journal-title":"BMC Gastroenterol"},{"issue":"1\u20132","key":"ref24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2013.12.020","article-title":"Epigenetic priming of memory updating during reconsolidation to attenuate remote fear memories","volume":"156","author":"Gr\u00e4ff J","year":"2014","unstructured":"Gr\u00e4ff J, Joseph NF, Horn ME, Samiei A, Meng J, Seo J et al (2014) Epigenetic priming of memory updating during reconsolidation to attenuate remote fear memories. Cell 156(1\u20132):261\u2013276","journal-title":"Cell"},{"issue":"22","key":"ref25","doi-asserted-by":"crossref","first-page":"e2116797119","DOI":"10.1073\/pnas.2116797119","article-title":"The HDAC inhibitor CI-994 acts as a molecular memory aid by facilitating synaptic and intracellular communication after learning","volume":"119","author":"Burns AM","year":"2022","unstructured":"Burns AM, Farinelli-Scharly M, Hugues-Ascery S, Sanchez-Mut JV, Santoni G, Gr\u00e4ff J (2022) The HDAC inhibitor CI-994 acts as a molecular memory aid by facilitating synaptic and intracellular communication after learning. Proc Natl Acad Sci U S A 119(22):e2116797119","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41419-018-0543-8","article-title":"Class I histone deacetylase (HDAC) inhibitor CI-994 promotes functional recovery following spinal cord injury","volume":"9","author":"Zhang S","year":"2018","unstructured":"Zhang S, Fujita Y, Matsuzaki R, Yamashita T (2018) Class I histone deacetylase (HDAC) inhibitor CI-994 promotes functional recovery following spinal cord injury. Cell Death Dis 9(5):460","journal-title":"Cell Death Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"648023","DOI":"10.3389\/fonc.2021.648023","article-title":"Combination Treatment of CI-994 With Etoposide Potentiates Anticancer Effects Through a Topoisomerase II-Dependent Mechanism in Atypical Teratoid\/Rhabdoid Tumor (AT\/RT)","volume":"11","author":"Kim HY","year":"2021","unstructured":"Kim HY, Choi SA, Koh EJ, Kim KH, Phi JH, Lee JY et al (2021) Combination Treatment of CI-994 With Etoposide Potentiates Anticancer Effects Through a Topoisomerase II-Dependent Mechanism in Atypical Teratoid\/Rhabdoid Tumor (AT\/RT). Front Oncol 11:648023","journal-title":"Front Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"112431","DOI":"10.1016\/j.biopha.2021.112431","article-title":"Epigenetic therapy combination of UNC0638 and CI-994 suppresses breast cancer via epigenetic remodeling of BIRC5 and GADD45A","volume":"145","author":"Lin HY","year":"2022","unstructured":"Lin HY, Wu HJ, Chen SY, Hou MF, Lin CS, Chu PY (2022) Epigenetic therapy combination of UNC0638 and CI-994 suppresses breast cancer via epigenetic remodeling of BIRC5 and GADD45A. Biomed Pharmacother 145:112431","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/npp.2013.346","article-title":"HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation","volume":"39","author":"Montalvo-Ortiz JL","year":"2014","unstructured":"Montalvo-Ortiz JL, Keegan J, Gallardo C, Gerst N, Tetsuka K, Tucker C et al (2014) HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation. Neuropsychopharmacology 39(6):1469\u20131478","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12035-014-8751-4","article-title":"Valproic Acid Alleviates Memory Deficits and Attenuates Amyloid-\u03b2 Deposition in Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"51","author":"Xuan A-G","year":"2015","unstructured":"Xuan A-G, Pan X-B, Wei P, Ji W-D, Zhang W-J, Liu J-H et al (2015) Valproic Acid Alleviates Memory Deficits and Attenuates Amyloid-\u03b2 Deposition in Transgenic Mouse Model of Alzheimer\u2019s Disease. Mol Neurobiol 51(1):300\u2013312","journal-title":"Mol Neurobiol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-49172-0","article-title":"Targeting central immune signaling enhances the effects of methylphenidate in alleviating apathy-like behavior in 5xFAD mice","volume":"16","author":"Monteiro R","year":"2026","unstructured":"Monteiro R, Dunn JT, Rodriguez G, Fisher DW, Dong H (2026) Targeting central immune signaling enhances the effects of methylphenidate in alleviating apathy-like behavior in 5xFAD mice. Sci Rep. ;16(1)","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"113192","DOI":"10.1016\/j.bbr.2021.113192","article-title":"Comparison of memory, affective behavior, and neuropathology in APP(NLGF) knock-in mice to 5xFAD and APP\/PS1 mice","volume":"404","author":"Locci A","year":"2021","unstructured":"Locci A, Orellana H, Rodriguez G, Gottliebson M, McClarty B, Dominguez S et al (2021) Comparison of memory, affective behavior, and neuropathology in APP(NLGF) knock-in mice to 5xFAD and APP\/PS1 mice. Behav Brain Res 404:113192","journal-title":"Behav Brain Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2025.11.035","article-title":"Impact of 5-HT7 receptor gene deletion on memory and affective behaviors in young and aged mice","volume":"592","author":"Rodriguez G","year":"2026","unstructured":"Rodriguez G, Zhao X, Neugebauer NM, Meltzer HY, Dong H (2026) Impact of 5-HT7 receptor gene deletion on memory and affective behaviors in young and aged mice. Neuroscience 592:191\u2013200","journal-title":"Neuroscience"},{"issue":"24","key":"ref34","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher M","year":"2001","unstructured":"G\u00f6ttlicher M, Minucci S, Zhu P, Kr\u00e4mer OH, Schimpf A, Giavara S et al (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. Embo j 20(24):6969\u20136978","journal-title":"Embo j"},{"issue":"2","key":"ref35","first-page":"166","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs","volume":"3","author":"Kim HJ","year":"2011","unstructured":"Kim HJ, Bae SC (2011) Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 3(2):166\u2013179","journal-title":"Am J Transl Res"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1073\/pnas.0510341103","article-title":"The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases","volume":"103","author":"Simonini MV","year":"2006","unstructured":"Simonini MV, Camargo LM, Dong E, Maloku E, Veldic M, Costa E et al (2006) The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci U S A 103(5):1587\u20131592","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/ijc.22751","article-title":"Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group","volume":"121","author":"Beckers T","year":"2007","unstructured":"Beckers T, Burkhardt C, Wieland H, Gimmnich P, Ciossek T, Maier T et al (2007) Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int J Cancer 121(5):1138\u20131148","journal-title":"Int J Cancer"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1016\/j.bmc.2007.12.007","article-title":"Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts","volume":"16","author":"Gediya LK","year":"2008","unstructured":"Gediya LK, Belosay A, Khandelwal A, Purushottamachar P, Njar VC (2008) Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts. Bioorg Med Chem 16(6):3352\u20133360","journal-title":"Bioorg Med Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"148951","DOI":"10.1016\/j.brainres.2024.148951","article-title":"Class 1 histone deacetylases differentially modulate memory and synaptic genes in a spatial and temporal manner in aged and APP\/PS1 mice","volume":"1837","author":"McClarty BM","year":"2024","unstructured":"McClarty BM, Rodriguez G, Dong H (2024) Class 1 histone deacetylases differentially modulate memory and synaptic genes in a spatial and temporal manner in aged and APP\/PS1 mice. Brain Res 1837:148951","journal-title":"Brain Res"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.molcel.2014.08.013","article-title":"c-Abl stabilizes HDAC2 levels by tyrosine phosphorylation repressing neuronal gene expression in Alzheimer's disease","volume":"56","author":"Gonzalez-Zu\u00f1iga M","year":"2014","unstructured":"Gonzalez-Zu\u00f1iga M, Contreras PS, Estrada LD, Chamorro D, Villagra A, Zanlungo S et al (2014) c-Abl stabilizes HDAC2 levels by tyrosine phosphorylation repressing neuronal gene expression in Alzheimer's disease. Mol Cell 56(1):163\u2013173","journal-title":"Mol Cell"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.18632\/aging.100906","article-title":"Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice","volume":"8","author":"Gri\u00f1\u00e1n-Ferr\u00e9 C","year":"2016","unstructured":"Gri\u00f1\u00e1n-Ferr\u00e9 C, Sarroca S, Ivanova A, Puigoriol-Illamola D, Aguado F, Camins A et al (2016) Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice. Aging 8(4):664\u2013684","journal-title":"Aging"},{"issue":"6","key":"ref42","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.celrep.2017.07.044","article-title":"The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons","volume":"20","author":"Yamakawa H","year":"2017","unstructured":"Yamakawa H, Cheng J, Penney J, Gao F, Rueda R, Wang J et al (2017) The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons. Cell Rep 20(6):1319\u20131334","journal-title":"Cell Rep"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1523\/JNEUROSCI.5052-10.2011","article-title":"HDAC3 is a critical negative regulator of long-term memory formation","volume":"31","author":"McQuown SC","year":"2011","unstructured":"McQuown SC, Barrett RM, Matheos DP, Post RJ, Rogge GA, Alenghat T et al (2011) HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci 31(2):764\u2013774","journal-title":"J Neurosci"},{"issue":"38","key":"ref44","doi-asserted-by":"crossref","first-page":"13124","DOI":"10.1523\/JNEUROSCI.0914-15.2015","article-title":"Histone Deacetylase Inhibition via RGFP966 Releases the Brakes on Sensory Cortical Plasticity and the Specificity of Memory Formation","volume":"35","author":"Bieszczad KM","year":"2015","unstructured":"Bieszczad KM, Bechay K, Rusche JR, Jacques V, Kudugunti S, Miao W et al (2015) Histone Deacetylase Inhibition via RGFP966 Releases the Brakes on Sensory Cortical Plasticity and the Specificity of Memory Formation. J Neurosci 35(38):13124\u201313132","journal-title":"J Neurosci"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/acschemneuro.0c00721","article-title":"PT3: A Novel Benzamide Class Histone Deacetylase 3 Inhibitor Improves Learning and Memory in Novel Object Recognition Mouse Model","volume":"12","author":"Pulya S","year":"2021","unstructured":"Pulya S, Mahale A, Bobde Y, Routholla G, Patel T, Swati et al (2021) PT3: A Novel Benzamide Class Histone Deacetylase 3 Inhibitor Improves Learning and Memory in Novel Object Recognition Mouse Model. ACS Chem Neurosci 12(5):883\u2013892","journal-title":"ACS Chem Neurosci"},{"issue":"6598","key":"ref46","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1126\/science.abk0297","article-title":"Circadian alignment of early onset caloric restriction promotes longevity in male C57BL\/6J mice","volume":"376","author":"Acosta-Rodr\u00edguez V","year":"2022","unstructured":"Acosta-Rodr\u00edguez V, Rijo-Ferreira F, Izumo M, Xu P, Wight-Carter M, Green CB et al (2022) Circadian alignment of early onset caloric restriction promotes longevity in male C57BL\/6J mice. Science 376(6598):1192\u20131202","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1429880","DOI":"10.3389\/fnmol.2024.1429880","article-title":"Pharmacological HDAC3 inhibition alters memory updating in young and old male mice","volume":"17","author":"Smies CW","year":"2024","unstructured":"Smies CW, Bellfy L, Wright DS, Bennetts SG, Urban MW, Brunswick CA et al (2024) Pharmacological HDAC3 inhibition alters memory updating in young and old male mice. Front Mol Neurosci 17:1429880","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/embor.2008.222","article-title":"Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease","volume":"10","author":"Belyaev ND","year":"2009","unstructured":"Belyaev ND, Nalivaeva NN, Makova NZ, Turner AJ (2009) Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep 10(1):94\u2013100","journal-title":"EMBO Rep"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jnc.12680","article-title":"The A\u03b2-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain","volume":"130","author":"Kerridge C","year":"2014","unstructured":"Kerridge C, Belyaev ND, Nalivaeva NN, Turner AJ (2014) The A\u03b2-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain. J Neurochem 130(3):419\u2013431","journal-title":"J Neurochem"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11064-012-0708-2","article-title":"Neuroinflammation and synaptic loss","volume":"37","author":"Rao JS","year":"2012","unstructured":"Rao JS, Kellom M, Kim HW, Rapoport SI, Reese EA (2012) Neuroinflammation and synaptic loss. Neurochem Res 37(5):903\u2013910","journal-title":"Neurochem Res"},{"issue":"11","key":"ref51","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/alz.12610","article-title":"Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis","volume":"18","author":"Lecca D","year":"2022","unstructured":"Lecca D, Jung YJ, Scerba MT, Hwang I, Kim YK, Kim S et al (2022) Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis. Alzheimer's Dement 18(11):2327\u20132340","journal-title":"Alzheimer's Dement"},{"issue":"14","key":"ref52","doi-asserted-by":"crossref","first-page":"11757","DOI":"10.3390\/ijms241411757","article-title":"The Molecular Mechanisms of Neuroinflammation in Alzheimer\u2019s Disease, the Consequence of Neural Cell Death","volume":"24","author":"Choi S-B","year":"2023","unstructured":"Choi S-B, Kwon S, Kim J-H, Ahn N-H, Lee J-H, Yang S-H (2023) The Molecular Mechanisms of Neuroinflammation in Alzheimer\u2019s Disease, the Consequence of Neural Cell Death. Int J Mol Sci 24(14):11757","journal-title":"Int J Mol Sci"},{"issue":"22","key":"ref53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252211941","article-title":"Neuroinflammatory Biomarkers in Alzheimer's Disease: From Pathophysiology to Clinical Implications","volume":"25","author":"Roveta F","year":"2024","unstructured":"Roveta F, Bonino L, Piella EM, Rainero I, Rubino E (2024) Neuroinflammatory Biomarkers in Alzheimer's Disease: From Pathophysiology to Clinical Implications. Int J Mol Sci. ;25(22)","journal-title":"Int J Mol Sci"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1700692","DOI":"10.3389\/fncel.2025.1700692","article-title":"Microglia-orchestrated neuroinflammation and synaptic remodeling: roles of pro-inflammatory cytokines and receptors in neurodegeneration","volume":"19","author":"Yang G","year":"2025","unstructured":"Yang G, Xu X, Gao W, Wang X, Zhao Y, Xu Y (2025) Microglia-orchestrated neuroinflammation and synaptic remodeling: roles of pro-inflammatory cytokines and receptors in neurodegeneration. Front Cell Neurosci 19:1700692","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"ref55","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/ptr.70317","article-title":"Microglial Activation Under Hypoxic Conditions in Early Alzheimer's Disease: Can Natural SIRT1 Activators Be Therapeutic Allies in the Inflammation\u2013Energy Axis?","volume":"40","author":"Merlo S","year":"2026","unstructured":"Merlo S, Lipari CLR, Patti A, Sortino MA (2026) Microglial Activation Under Hypoxic Conditions in Early Alzheimer's Disease: Can Natural SIRT1 Activators Be Therapeutic Allies in the Inflammation\u2013Energy Axis? Phytother Res 40(6):3354\u20133368","journal-title":"Phytother Res"},{"issue":"7","key":"ref56","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41423-026-01438-3","article-title":"Microglia and neuroinflammation: function, heterogeneity, and crosstalk","volume":"23","author":"Zong S","year":"2026","unstructured":"Zong S, Cui X, Wu S, Lu Z (2026) Microglia and neuroinflammation: function, heterogeneity, and crosstalk. Cell Mol Immunol 23(7):787\u2013805","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/rheumatology\/keq108","article-title":"Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells","volume":"49","author":"Choo QY","year":"2010","unstructured":"Choo QY, Ho PC, Tanaka Y, Lin HS (2010) Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells. Rheumatology (Oxford) 49(8):1447\u20131460","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pupt.2012.05.003","article-title":"Smoke exposure of human macrophages reduces HDAC3 activity, resulting in enhanced inflammatory cytokine production","volume":"25","author":"Winkler AR","year":"2012","unstructured":"Winkler AR, Nocka KN, Williams CM (2012) Smoke exposure of human macrophages reduces HDAC3 activity, resulting in enhanced inflammatory cytokine production. Pulm Pharmacol Ther 25(4):286\u2013292","journal-title":"Pulm Pharmacol Ther"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cbpa.2016.06.019","article-title":"Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-\u03baB-mediated inflammation","volume":"33","author":"Leus NG","year":"2016","unstructured":"Leus NG, Zwinderman MR, Dekker FJ (2016) Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-\u03baB-mediated inflammation. Curr Opin Chem Biol 33:160\u2013168","journal-title":"Curr Opin Chem Biol"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbrc.2015.11.086","article-title":"Stimulation of nuclear receptor REV-ERBs regulates tumor necrosis factor-induced expression of proinflammatory molecules in C6 astroglial cells","volume":"469","author":"Morioka N","year":"2016","unstructured":"Morioka N, Tomori M, Zhang FF, Saeki M, Hisaoka-Nakashima K, Nakata Y (2016) Stimulation of nuclear receptor REV-ERBs regulates tumor necrosis factor-induced expression of proinflammatory molecules in C6 astroglial cells. Biochem Biophys Res Commun 469(2):151\u2013157","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/jnc.14144","article-title":"Inhibition of histone deacetylase 1 or 2 reduces induced cytokine expression in microglia through a protein synthesis independent mechanism","volume":"143","author":"Durham BS","year":"2017","unstructured":"Durham BS, Grigg R, Wood IC (2017) Inhibition of histone deacetylase 1 or 2 reduces induced cytokine expression in microglia through a protein synthesis independent mechanism. J Neurochem 143(2):214\u2013224","journal-title":"J Neurochem"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1038\/s41598-017-08535-4","article-title":"HDAC3 inhibition ameliorates spinal cord injury by immunomodulation","volume":"7","author":"Kuboyama T","year":"2017","unstructured":"Kuboyama T, Wahane S, Huang Y, Zhou X, Wong JK, Koemeter-Cox A et al (2017) HDAC3 inhibition ameliorates spinal cord injury by immunomodulation. Sci Rep 7(1):8641","journal-title":"Sci Rep"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10816126\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10816126\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:34:32Z","timestamp":1787769272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10816126\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":62,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10816126\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,8,26]]},"subtype":"preprint"}}